教育情况：

1978.12  医学博士，西安交大、西安医科大学（医学院）

1987.06  北京大学硕士/北京医学大学（肿瘤生物学）

1994.06  分子药理学博士：纽约布法洛城州立大学

工作经历：

1987.07-1989.08  讲师，北京大学/北京医科大学病理

1994.07-1995.06  病理学博士后，纽黑文耶鲁大学

1995.07-1996.06  NCI 病理肿瘤研究员，纽黑文耶鲁大学

1996.07-2000.06  病理及医学实验室住院医师，纽黑文耶鲁纽黑文医院

1998.07-1999.01  行政总住院医师，病理解剖，耶鲁纽黑文医院，

2000.07-2001 肿瘤病理研究员，纽约纪念Sloan-Kettering癌症中心

2001-2007.06  病理学助理教授，纽黑文耶鲁大学医学院

2007.07-2013.06  病理学副教授，纽黑文耶鲁大学医学院

2011.07至今 产科、妇科和生殖科副教授，纽黑文耶鲁大学医学院（联合任命）

2013.07至今 病理学教授，纽黑文耶鲁大学医学院

职务：

2005.07至今  纽黑文耶鲁大学医学院临床分子诊断学、病理科 临床主任

2012.12至今  纽黑文耶鲁大学医学院，妇科病理、病理科  主任

2013.12至今  纽黑文耶鲁大学医学院，妇科和乳腺病理科 主任

Name: Pei Hui M.D., Ph.D.

Professor of Pathology

Director, Gynecologic Pathology

Director, Gynecologic and Breast Pathology Fellowship Program Director, Clinical Molecular Diagnostics Laboratories in Pathology

Yale University School of Medicine

Office Address:

Department of Pathology

BML254B

Yale University School of Medicine

310 Cedar Street

New Haven, CT06520, USA

Education:

M.D. Xian Jiao Tong University/Xian Medical University (Faculty of Medicine) 1984-06

M.S. Peking University/Beijing Medical University (Tumor Biology) 1987-06

Ph.D. State University of New York at Buffalo (Molecular Pharmacology) 1994-06

Career/Academic Appointments:

1987-07 to 1989-08 Instructor of Pathology, Peking University/Beijing Medical University

1994-07 to 1995-06 Postdoctoral Fellow in Pathology, Yale University, New Haven, CT

1995-07 to 1996-06 NCI Oncology Research Fellow, Department of Pathology, Yale University, New Haven, CT

1996-07 to 2000-06 Resident, Pathology and Laboratory Medicine, Yale-New Haven Hospital, New Haven, CT

1998-07 to 1999-01 Administrative Chief Resident, Anatomic Pathology, Yale-New Haven Hospital, New Haven, CT

2000-07 to 2001-06 Pathology Fellow, Oncological Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY

2001-07 to 2007-06 Assistant Professor of Pathology, Yale University School of Medicine, New Haven, CT

2007-07 to 2013-06 Associate Professor of Pathology, Yale University School of Medicine, New Haven, CT

2011-07 to present Associate Professor of Obstetric, Gynecology and Reproductive Sciences, Yale University School of Medicine (joint appointment), New Haven, CT

2013-07 to present Professor of Pathology, Yale University School of Medicine, New Haven, CT

Administrative Positions:

2005-07 to present Clinical Director, Clinical Molecular Diagnostics, Department of Pathology, Yale University School of Medicine, New Haven, CT

2012-12 to present Director, Gynecologic Pathology, Department of Pathology, Yale University School of Medicine, New Haven, CT

2013-12 to present Director, Gynecologic and Breast Pathology Fellowship Program, Department of Pathology, Yale University School of Medicine, New Haven, CT

Board Certification:

American Board of Pathology, Anatomic and Clinical Pathology, 2000

American Board of Medical Genetics/American Board of Pathology, Molecular Genetic Pathology, 2003

Professional Honors & Recognitions (list from most recent to earliest):

International/National/Regional

2011 Scholarship, College of American Pathologist (2011 CAP Policy Meeting, Washington D.C.)

2009 Certificate of Qualification (Oncology-Molecular and Cellular Tumor Markers), New York State Department of Health, 2009

2008 Recognition Award, Asociacion Mexicana de Pathologos A.C., Mexico

2005 Editorial Award, Chinese Journal of Pathology/Chinese Society of Pathology

2002 Resident Research Excellence Award - International Society of Urological Pathology

2001 F. Stephen Vogel Award - United States and Canadian Academy of Pathology

1996 Fellowship, Annual Diagnostic Pathology Summer School, The Chinese University of Hong Kong

1995 Cornell-China Bridge International Fellowship - The Rockefeller Foundation (Three year term: 1995 to 1997)

1995 International Exchange Fellowship - China National Natural Science Foundation)

1994 Molecular Oncology Fellowship Award - Anna Fuller Fund, Yale University

1989 National Science Award - China Ministry of Education

1988 Science Advancement Award - Beijing Science Society

Yale University

2007 Nomination for the 2007 Alice Bohmfalk Teaching Award in Basic Science, Yale School of Medicine.

Grant/Clinical Trials History:

Agency: Pilot Research Grant

I.D.#

Title: Oncological and Obstetric Outcomes of Excisional Treatment for Cervical Cancer Precursors in Reproductive Age Women

P.I.: Divya A Patel

Percent effort: 1%

Direct costs per year:  12,500

Total cost for project period:  $25,000

Project period:  01/01/12 – 12/31/12

Agency: Third Wave Technologies, Inc

I.D.# Collaborative Research Grant

Title: A Study to Evaluate the Analytical and Clinical Performance of the Invader(r) HPV Reagents

P.I.: P Hui

Percent effort:  5%

Total costs for projected period:  $47,190

Projected period:  7/1/2007 - 6/30/2008

Agency: China Bridge International Foundation

China National Science Foundation

I.D.# China-Cornell Fellowship

Title:

P.I.: P Hui

Percent Effort:  5%

Total costs for projected period:  $7,650

Projected period:  5/01/1994 - 4/30/1997

Agency: NCI/NIH

I.D.# National Research Service Award

Title: EVI-1 Oncoprotein in Leukemogenesis

P.I.: P Hui

Percent Effort: 100%

Total costs for projected period:  $40,375

Projected period:  4/1/1995 -6/30/1997

Agency: Anna Fuller Fund, Yale University

I.D.# Molecular Oncology Fellowship

Title: Molecular study of zinc finger gene 1 (MZF-1) in hematopoiesis

P.I.: P Hui

Percent Effort: 100%

Total costs for projected period:  $32,800

Projected period:  7/1/1994 - 6/30/1995

Agency: Mark Diamond Research Foundation

I.D.# State University of New York

Title: Molecular characterization of myeloid zinc finger gene 1 (MZF-1)

P.I.: P Hui

Percent Effort: 10%

Total costs for projected period:  $2,000

Projected period:  7/19/1993-6/30/1994

Invited Speaking Engagements, Presentations, Symposia &

Workshops Not Affiliated With Yale: (list from most recent to earliest)

Scheduled National and International Presentations, Courses, Symposium and Workshops:

2016: Keynote Lecture: Gestational Trophoblastic Disease. International Congress of Gynecologic Pathology (ISGyP and IAP-Chinese Division), October 29-30, 2016, Beijing, China

International/National:

2013- 2015: USCAP Short Course (Course Director): Gestational Trophoblastic Disease in the Molecular Era (Dr. Brigitte Ronnett, Co-director). The USCAP Annual Meeting, March 22-26, 2015.

2015: Symposium  (faculty) – Update of Immunohistochemistry in the Diagnosis of Gynecologic Pathology, CAPA (Chinese American Pathologist Association), August 20, New York, New York.

2014: Symposium (ISGyP) - A critical Review of the 2014 WHO Pathological Classification of Tumors and the Female Genital Trace:  Trophoblastic Disease - Diagnostic Problems and Classification. The IGCS Biennial Meeting, November 8 - 14, 2014, Melbourne, Australia.

2014: Pathology Grand Rounds: Gestational Trophoblastic Disease: Molecular Integration to Meet the Diagnostic Challenges. MD Anderson Cancer Center, April 18, 2014, Houston, Texas.

2011-2013: USCAP Special Course (course faculty): Tissue Genotyping for Routine Diagnostic Pathology, in "Introduction to Molecular pathology: Basic Principles and Practical Applications". Course Director: Dr. Jennifer Hunt, M.D., USCAP Annual Meeting, Baltimore, March 4, 2013.

2012: Gestational Trophoblastic Disease Symposium (Invited speaker): Molecular Diagnosis of Gestational Trophoblastic Disease. IAP XXIX International Congress, Cape Town, South Africa, September 29 - October 5, 2012.

ASCP Short Course (Course Director): Precision Diagnosis of Gestational Trophoblastic Disease in the Molecular Era, ASCP Annual Meeting, October 31-November 3, 2012.

Invited Presentation: BRAF Mutation Testing in Clinical Practice of Oncology, Morning Session - Molecular Pathology as the Driving Force for Personalized Oncology at Innovative Tissue – Based Cancer Diagnostics Congress (Cambridge Healthtech Institute-CHI), Philadelphia, June 5, 2012.

Chinese American Pathologist Association (CAPA) 10th Annual Meeting Scientific Program (Invited speaker): Molecular Pathology for General Pathologists: Now and Future. In conjunction with USCAP Annual Meeting, Vancouver, March 17, 2012.

2011: ASCP Workshop (course faculty): A Practical Approach to Molecular Diagnosis in Gynecologic Neoplasms (Course director: Dr. David Chhieng), ASCP Annual Meeting/WASPaLM XXVI World Congress, October 19-22, 2011, Las Vegas, Nevada.

Invited Lecture: Next generation DNA sequencing. The 7th Forum of Mainland and Overseas Pathologists (IAP-Chinese Division), June 4, 2011, Beijing, People's Republic of China.

Pathobiology Seminar: Gestational Trophoblastic Disease in the Molecular Era. Department of Pathology, University of Chicago, January 18, 2011.

2010: Research Seminar: Gestational Trophoblastic Disease: Biology, Genetics and Modern Medicine, Department of Pathology, Northwestern University, November 8, 2010.

Diagnostic Pathology Short Course: Ovarian Pathology, The Sixth Forum of Mainland and Overseas Pathologists (IAP-Chinese Division), Beijing, September 28, 2010.

Pathology Seminar: Gestational Trophoblastic Diseases: An Emerging Molecular Revolution. Department of Pathology, University of Florida College of Medicine, Gainesville, March 5, 2010.

Invited Presentation: Diagnosis of gestational trophoblastic diseases: Emerging molecular revolution. The 15th Annual Convention and Gala, Association of Chinese American Physician, New York, May 23th, 2010.

Invited Presentation: Inside and outside tyrosine kinase receptors: molecular testing toward personalized cancer care. The Fifth Forum of Mainland and Overseas Pathologists (IAP-Chinese Division), Beijing, China, January 30, 2010.

Lecture: Gestational trophoblastic diseases: an impending molecular revolution. Xi'an Jiaotong University, Second Teaching Hospital, Xi'an, China. April 12, 2010.

Lecture: Microstructures for Diagnostic Pathology - Medical School English Lecture Series, The Forth Military Medical University, Xi'an, China, April 13, 2010.

Invited Presentation: Pathological Diagnosis of Gestational Trophoblastic Diseases in the Molecular Era. The 11th Congress of the Chinese Society of Pathologists/Chinese Journal of Pathology, Chongquing, China, April 17, 2010.

Invited Presentation: Molecular Diagnosis of Cutaneous Lymphomas. Peking Union University School of Medicine, Department of Dermatology. Beijing, September 18, 2010.

2009: Pathology Grand Rounds: Gestational Trophoblastic Disease in the Molecular Era: Genomic Imprinting, X chromosomal inactivation and Molecular Diagnosis. Yale University, March 19, 2009

Update Lecture in Medical Oncology: Molecular Diagnosis of Cancer (Yale Cancer Center - Greece Week), July 6, 2009.

Lecture: Type II Endometrial carcinoma: precursor lesions, histological diagnosis and therapeutic markers.  Xi'an Jiaotong University, May 11, 2009.

Invited Presentation: Molecular Diagnosis of Cancer. Xi'an Jiaotong University First Hospital, May 12, 2009.

Seminar: Molecular Diagnosis of Cancer. Shaanxi University of Chinese Traditional Medicine, May 13, 2009.

Lecture: Endometrial serous carcinoma: precursor lesions, histological diagnosis and therapeutic markers. The Fourth Forum of Mainland and Overseas Pathologists (IAP-Chinese Division), Beijing, May 15, 2009.

Lecture: Gestational trophoblastic diseases: Pathology in the molecular era. The Fourth Forum of Mainland and Overseas Pathologists (IAP-Chinese Division), Beijing, China, May 16, 2009.

Lecture: DNA Sequencing and Data Interpretation. Department of Pathology, Peking University Health Science Center, May 18, 2009.

2008: International Internet Lecture: Biopsy diagnosis of endometrial carcinoma. IPATHOLOGY.ORG.  April 5 2008.

Keynote Lecture (Conferencia Magistral): Trophoblastic Diseases: Recent advances in histopathology Diagnosis and Related genetic Aspects. The 51th Annual Congress of the Mexican Association of Pathologists, Huatulco, Oaxaca, Mexico May 1-4, 2008.

2007: Platform presentation: Placental site trophoblastic tumor: novel genetic mode of oncogenesis that excludes the presence of Y chromosome. USCAP Annual Meeting, San Diego, 2007.

International Internet Lecture:  Cervical Squamous Lesions. IPATHOLOGY.ORG. June 27, 2007.

International Internet lecture: Cervical Glandular Lesions. IPATHOOGY.ORG. July 26, 2007.

Diagnostic Pathology Short Course: GYN Pathology, The Third Forum of Mainland and Overseas Pathologists (IAP-Chinese Division), Beijing, 2007.

Diagnostic Pathology Lecture: Diagnostic Issues of Cervical Lesions.  Peking University, 2007.

2006: Diagnostic Pathology Short Course: GYN Pathology, The Second Forum of Mainland and Overseas Pathologists (IAP-Chinese Division). Fuzhou, China, 2006.

2005: Lecture: Molecular studies of placental site trophoblastic tumor.  HuaTou Pathology Society, Chicago, June 27, 2005.

Diagnostic Pathology Short Course: GYN Pathology, The Forum of Mainland and Overseas Pathologists (IAP-Chinese Division), Beijing, 2005.

Lecture: Applications of real-time PCR in human solid tumors: diagnosis and assessment for therapeutic response. Molecular Pathology Session, The 4th Asia-Pacific IAP Congress, August 23 - 26, 2005 Beijing, China.

Lecture:  Minimal uterine serous carcinoma: a search for its precursor lesions and clinicopathological correlations, Gynecologic Pathology Session, The 4th Asia-Pacific IAP Congress, August 23 - 26, 2005 Beijing, China.

2004: Keynote Lecture: Histological and molecular diagnosis of mantle cell lymphoma.  Annual Meeting, Chinese Society of Pathology, Guiyang, China, 2004.

2003: Invited presentation: Gestational trophoblastic diseases: paternal X chromosome and genomic imprinting.  January 18, 2003, Laboratory Medicine, Yale University.

2001: Seminar: Molecular Diagnosis of Mantle Cell Lymphoma: A Comparative Study. Department of Pathology, Pennsylvania State University, Hershey Medical Center, January 12, 2001.

Seminar: Paternal X Chromosome in the Pathogenesis of Human Gestational Trophoblastic Diseases. Department of Pathology, University of Chicago, February 8, 2001.

Seminar: Molecular Diagnosis of Mantle Cell Lymphoma: A Comparative Study", University of California at Irvine, March 9, 2001.

2000: Seminar: Paternal X chromosome in the pathogenesis of gestational trophoblastic diseases. Department of Pathology and Laboratory Medicine, University of Pennsylvania, December 13, 2000.

1999: Platform presentation: Placental site trophoblastic tumor tends to occur following a female conceptus and is a clonal process. The 88th USCAP Annual Meeting, Boston, 1999.

Platform presentation: Enhanced tumor suppression of mouse p53 (172 Arg-Leu mutant).  The 88th  USCAP Annual Meeting, Boston, 1999.

1995: Seminar: Molecular cloning and structural analysis of the Human Myeloid Zinc Finger Gene -1 (MZF-1). The People's Hospital of Beijing Medical University/Peking University, Beijing, China, 1995.

1992 Podium Presentation: Molecular cloning and stable expression of MZF-1 gene in human myeloid leukemia cell line - K562. Eleventh Annual Pharmacology and Toxicology Graduate Student Symposium of Western New York, University of Rochester, November, 1992.

Podium Presentation: Functional and structural characterization of the MZF-1 gene. A potential transcription factor critical to hematopoiesis. Pharmaceutical Sciences Day, Center for Tomorrow, SUNY at Buffalo, May, 1992.

1989: Podium Presentation: Carcinogenesis on xenografts of human fetal tracheobronchi. First Congress of Asia Pacific Association of Societies of Pathologists. Beijing, 1989.

1988: Platform Presentation: Carcinoma induction on xenotransplants of human fetal tracheobronchi. The 6th International Workshop on Immune-deficient Animals. Beijing, China, 1988.

PROFESSIONAL SERVICE

Peer Review Groups/Grant Study Section: (list from most recent to earliest)

2012: Chairman’s challenge grant for trainees, Department of Pathology, Yale University School of Medicine

2011: Chairman’s challenge grant for trainees, Department of Pathology, Yale University School of Medicine

2009: Translational Science and Specific Challenge Topic 15-CA-102, Center for Scientific Review (CSR), National Institutes of Health, 2009.

Yale Center of Excellence in Molecular Hematology Pilot and Feasibility Programs (YCEMH P&F Pilot), 2009.

Journal Editorial Board Service

2016 Editorial Board, Human Pathology

2015 Editorial Board, American Journal of Clinical Pathology

2014 International Advisory Board, Journal of Clinical Pathology

2013 Editorial Board, International Journal of Gynecological Pathology

2009 Editorial Board, Pathology and Laboratory Medicine International

2009 Editorial Board, Chinese Journal of Pathology

2008 Editorial Board, International Journal of Clinical and Experimental Pathology

2005 Overseas Editorial Board, Chinese Journal of Clinical and Experimental Pathology

2002 Overseas Editorial Board, Chinese Journal of Pathology

Journals Ad HOC Reviewer (Since 1998):

Cancer

Laboratory Investigation

International Journal of Cancer

Pediatric and Developmental Pathology

Cancer Cytopathology

The Chinese Journal of Pathology

International Journal of Surgical Pathology

Virchows Archive

Archives of Pathology & Laboratory Medicine

International Journal of Gynecological Cancer

Reproductive Sciences

Nature Protocols

American Journal of Dermatopathology

Journal of Molecular Diagnostics

Journal of Colorectal Cancer

European Journal of Obstetrics and Gynecology and Reproductive Biology

International Journal of Gynecological Pathology

International Journal of Women's Health

PLOS One

International Journal of Gynecologic Pathology

Modern Pathology

American Journal of Pathology

American Journal of Clinical Pathology

Human Pathology

Histopathology

Professional Service for Professional Organizations: (list from most recent to earliest)

1) International Society of Gynecological Pathologists (ISGP)

2016 Congress President, International Congress of Gynecologic Pathology (ISGP and IAP-Chinese Division), Beijing, China

2016 Finance Committee, International Society of Gynecological Pathologists (ISGP)

2015-2017 Executive Board Officer /Board of Directors, International Society of Gynecological Pathologists (ISGP)

2012-2013: Chair, Gestational Trophoblastic Disease (GTD) Committee, WHO nomenclature/International Society of Gynecological Pathologists (ISGP)

2011-2012: Committee Member, Gestational Trophoblastic Disease (GTD) Committee. WHO nomenclature /International Society of Gynecological Pathologists (ISGP).

2). World Health Organization (WHO) – International Agency for Research on Cancer

2014: Responsible author, Gestational Trophoblastic Disease in WHO Classification of Tumours of Female Reproductive Organs 4th Edition, International Agency for Research on Cancer (IARC) of World Health Organization (WHO).

2013: Member, Consensus and Editorial Meeting, WHO Classification of Tumours of Female Reproductive Organs 4th Edition, WHO, Lyon, France, June 13-15, 2013.

3). International Gynecologic Cancer Society

2014: Co-Chair, Symposium (ISGyP) - A critical Review of the 2014 WHO Pathological Classification of Tumors and the Female Genital Trace. The IGCS Biennial Meeting, November 8 - 14, 2014, Melbourne, Australia.

4). Cambridge HealthTech Institute (CHI)

2012: Chair, Session of Molecular Pathology as the Driving Force for Personalized Oncology at Innovative Tissue – Based Cancer Diagnostics Congress (CHI), June 5, 2012, Philadelphia.

5). United States and Canadian Academy of Pathology (USCAP)

2013-15 Short Course Director, Gestational Trophoblastic Diseases in the Molecular Era. USCAP Annual Meetings (three-year term).

2011-13 Faculty, Introduction to Molecular Pathology: Basic Principles and Practical Applications. Course Director: Jennifer Hunt, USCAP Annual Meetings.

2007-10 Session Chair/Co-Chair, Techniques Plenary Session, USCAP Annual Meetings

2005-07 Abstract review board, USCAP Annual Meetings

2005-present Ambassador, USCAP

6). American Society of Clinical Pathology (ASCP)

2012: Course Director: Precision Diagnosis of Gestational Trophoblastic Disease in the Molecular Era, ASCP Annual Meeting, October 31-November 3, 2012, Boston, Massachusetts

2011: Workshop Faculty, Practical approach to molecular diagnostics in gynecologic neoplasms. Course director: David Chhieng, ASCP Annual Meeting/WASPaLM XXVI World Congress, October 19-22, 2011, Las Vegas, Nevada

2007: Contributor, Resident In-Service Examination Committee, American Society for Clinical Pathology.

7). Pathology Foundation

2010-present: Council Member, The Wu Bingquan Pathology Development Foundation

8). College of American Pathologists (CAP)

2012: Tour Host, Yale Pathology Lab Tour for Congressman James Himes (Demarcate, Connecticut 4th District) in conjunction with CAP, June 13, 2012.

2011: Connecticut representative, CAP Annual Policy Meeting, May 2-4, Washington D.C.

Since 2008: Member, College of American Pathologist (CAP)

Since 1999:   Inspector (Molecular Pathology and Anatomic Pathology)

9) Gynecological Oncology Group (GOG)

2012: GOG Pathology Review Committee, Boston, July 26-28, 2012.

2011: GOG Pathology Review Committee, Philadelphia, January 14-16, 2011.

2010: GOG Pathology Review Committee, Boston, July 27-28, 2010.

2008-present: Yale Medical Center GOG Gynecological Pathologist.

10). The Chinese American Pathologist Association (CAPA)

2008-09 : Vise President, Chinese American Pathology Association

2007-10: Chairman, Education Committee

2006-07: Executive Member and Vice Chair of Education Committee

11). The Forum of Mainland and Overseas Pathologists (IAP-Chinese Division)

2005-present: Organizing Committee and faculty (6 GYN pathology short courses and 4 lectures given in the past 7 forums, 2005 through 2012).

12). The 4th Asia-Pacific IAP Congress (IAP-Chinese Division)

2005: Vice Chair, Scientific Committee, The 4th Asia-Pacific IAP Congress, August 23-26, 2005, Beijing, China.

Session Chair, Molecular Pathology, The 4th Asia-Pacific IAP Congress, August 23-26, 2005, Beijing, China.

13). Other Academic Organizations

2003-present Association of Molecular Pathology (AMP)

2002-present Associate member, Yale Comprehensive Cancer Center

1987-present Chinese Society of Pathology

14). Yale University Service (List from most recent to earliest)

Departmental Committees

2015-present Clinical Advisory Committee

2012-present: Faculty Mentor: Dr. Mina L Xu, MD (mentee), Assistant Professor of Pathology, Yale University School of Medicine.

2011-present: Faculty Mentor: Dr. Natalia Buza, MD (mentee), Assistant Professor of Pathology, Yale University School of Medicine.

2011-present:  Quality Assurance Committee, Department of Pathology, Yale University School of Medicine.

2010-present: Selection and Training Committee, Discovery to Cure, Clinical and Translational Research Fellowship, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University

2009-present: Assistant Director of Laboratories (under Dr. Brian West, Director of Laboratories, Molecular Oncology Testing and Certificate of Qualification - the New York State Department of Health), Department of Pathology, Yale University School of Medicine.

2009-present: Organizer, Yale-China Gynecological Oncology Program, Department of Obstetrics, Gynecology and Reproductive Sciences, and Department of Pathology, Yale University School of Medicine.

2009-present: Committee, Yale Urogynecology and Reconstructive Pelvic Surgery Fellowship Program, 2009-2012

2009-present: Immunohistochemistry Steering Committee, Department of Pathology, Yale University School of Medicine

2009-present: Resident Education Committee, Department of Pathology, Yale University School of Medicine

Hospital Committees

2009-present: Committee, Yale Gynecological Oncology Group (GOG) - Clinical Trial Programs

14). Visiting/Guest Professorship

2011- 2012: Guest Professor, Second Affiliated Hospital, Medical College of Xi’an Jiaotong University (China).

2010: Visiting Professor, University of Florida College of Medicine at Gainesville

2010-12: Guanghua Lecture Professor, Xi'an Jiaotong University (China)

2009-12: Guest Professor, Peking University (China)

2009-present: Visiting Professor, Shaanxi University of Traditional Chinese Medicine (China)

BIBLIOGRAPHY

Peer-Reviewed Original Research (list from earliest to most recent; do not include review articles, letters to editor or replies):

1. Hui P, Wu BQ, Yao X, Zheng J, Wang JL, You JF: Heterotransplantation of human fetal tracheobronchi and their long-term engraftment in nude mice. Chinese Journal of Pathology 1987, 16:89.

2. Hui P, Wu BQ, Zheng J, Wang JL, You JF: Heterotransplantation of human fetal tracheobronchial segments in nude mice and its application in carcinogenesis studies. Chinese Journal of Pathology 1988, 17:94.

3. Wu BQ, Hui P, Zheng J: In vitro establishment of a carcinoma cell line from benzo(a)pyrene treated human fetal bronchi grafted in vivo. Proceedings of the Society for Experimental Biology and Medicine 1989, 191:430.

4. Mu Y, Hui P: Computer aid software system for diagnosis of congenital malformation syndromes. National Medical Journal of China 1990, 70: 560.

5. Wu BQ, Zheng J, Fang WG, Wang JL, Hui P. Heterotransplantation of human tumors and their biological studies (review). Journal of Beijing Medical University 1989, 21:239-241.

6. Bradford PG, Jin YY, Hui P, Wang XH: IL-3 and GM-CSF induce the expression of the inositol triphosphate receptor in K562 myeloblast cells. Biochemic Biophys. Res. Comm. 1992, 187: 438-442.

7. Bradford PG, Wang XH, Jin YY, Hui P: Transcriptional regulation of the inositol triphosphate receptor during human leukemic cell differentiation. Journal of Biological Chemistry 1992, 267:20959-20964.

8. Bradford PG, Jin YY, Hui P: Vitamin D3 regulates transcription and functional expression of the inositol triphosphate Receptor in HL-60 cells. Molecular Pharmacology 1993, 44:292-297.

9. Mu Y, Hui P: Generation of single stranded DNA by unidirectional PCR and its application to direct sequencing of the human myeloid zinc finger gene (MZF-1). Chinese Biochemical Journal 1994, 10: 657-661.

10. Hui P, Gou X, Bradford PG:  Molecular cloning and structural analysis of the Human Myeloid Zinc Finger Gene -1 (MZF-1). Biochemistry 1995, 34:16493-16502.

11. Xie J, Wu BQ, Fang WG, Li BL, Li HM, Zheng J, Hui P. A study on the tumor suppressing effect of a specific point mutant p53 minigene in the expression regulated model with a tetracycline-transactivator response promoter. Chinese Journal of Pathology 1998, 27:328-332.

12. Kim, JK, Hui P, Aycock J, Leclerc C, Bjoring AR, Perkins AS: Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy. Oncogene 1998, 17: 1527-1538.

13. Xie J, Fang W, Hui P:  Specific point-mutations of p53 mini-gene affecting the biological behaviors of a human cancer cell line PG derived from human pulmonary giant carcinoma. National Medical Journal of China 1999, 79:57-60.

14. Hui P, Parkash V, Perkins AS, Carcangiu M: Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Laboratory Investigation 2000, 80: 965-972.

15. Ma Y, Wu B, Xie J, You J, Liu J, Cui X, Wang J, Hui P: Effect of mouse p53 minigene on lung cancer cells with different 172 structures regulated by tetracycline. Chinese Journal of Pathology 2000, 29:359-362.

16. Hui P, Perkins AS, Glusac E: Assessment of clonality in melanocytic nevi and melanoma. Journal of Cutaneous Pathology 2001, 28:140-144.

17. Jain D, Hui P, McNamara J, Schwartz D, German J, Reyes-Múgica M: Bloom syndrome in sibs: first reports of hepatocellular carcinoma and Wilms tumor with documented anaplasia and nephrogenic rests. Pediatric and Developmental Pathology 2001, 4:585-589.

18. Ma YH, Wu BQ,  Liu JY, You JF, Cui XL, Wang JL, Hui P. Study on the growth of H1299 cell line transfected transiently with mouse p53 minigenes with different codon 172 structures. Chinese Journal of Lung Cancer 2001, 4:94-98.

19. Zambrano E, Marshalko SJ, Jaffe, CC. and Hui P: Isolated Noncompaction of the Ventricular Myocardium: Clinical and Molecular Aspects of a Rare Cardiomyopathy. Laboratory Investigation 2002, 82: 117-122.

20. Hui P, Glusac EJ, Sinard J, Perkins AS: Clonal analysis of cutaneous fibrous histiocytoma (Dermatofibroma). Journal of Cutaneous Pathology 2002, 29:285-289.

21. Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder, B, Dillon D, Giuliano A, Cirafici A, Santoro, M, Rosai J, Tallini G: RET/PTC oncogene activation and assessment of clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. American Journal of Pathology 2002, 160:2157-67.

22. Hui P, Howe G, Crouch J, Qumsiyeh M, Tallini G, Flynn S, Smith B: Real-time RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.  Leukemia and Lymphoma 2003, 44:1385-1394.

23. Hui P, Riba A, Petrovic T, Johnson T, Baergen R, Ward D. Comparative genomic hybridization study of placental site trophoblastic tumor: successful analysis of four cases. Modern Pathology 2004, 17:248-251.

24. Bhattacharjee P, Hui P, McNiff J. Human herpesvirus-8 is not associated with angiolymphoid hyperplasia with eosinophilia. Cutaneous Patholology 2004, 31:612-5.

25. Li N, McNiff J, Hui P, Manfioletti G, Tallini G. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. American Journal of Dermatopathology 2004, 26:267-72.

26. Zhang SS, Wei J, Qin H, Zhang L, Xie B, Hui P, Deisseroth A, Barnstable CJ, Fu XY. STAT3-mediated signaling in the determination of rod photoreceptor cell fate in mouse retina. Investigative Ophthalmological Visual Sciences 2004, 45:2407-12.

27. Kelly MG, O'Malley D, Hui P, McAlpine J, Dziura J, Rutherford TJ, Azodi M, Chambers SK, Schwartz PE. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation. Gynecological Oncology 2004, 95: 469-473.

28. Fadare O, Parkash V, Yilmaz Y, Mariappan MR, Ma L, Hileeto D, Qumsiyeh MB, Hui P. Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis. World Journal of Surgical Oncology 2004, 2:35-47.

29. Hui P, Kelly M, O'malley DM, Tavassoli F, Schwartz PE. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Modern Pathology 2005, 18:75-82.

30. Yatsula B, Lin S, Read AJ, Poholek A, Yates K, Yue D, Hui P, Perkins AS. Identification of binding sites of EVI1 in mammalian cells. Journal of Biological Chemistry 2005, 280:30712-30722.

31. Kelly MG, O'Malley DM, Hui P, McAlpine J, Yu Y, Rutherford TJ, Azodi M, Schwartz PE. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.  Gynecologic Oncology 2005, 98:353-359.

32. Hui P, Li N, Johnson C, Sciot R, Manfioletti G, Tallini G. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in peripheral nerve sheath tumor. Modern Pathology 2005, 18:1519-26.

33. Xing MZ, William H. Westra WH, Ralph P. Tufano RP, Rosenbaum E, Cohen Y, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Elizabeth H. Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, and Ladenson PW. BRAF mutation predicts a poorer prognosis for papillary thyroid cancer. The Journal of Clinical Endocrinology & Metabolism 2005, 90:6373-7379.

34. Hui P, Fedoriw G. Recurrent endometrial stromal nodules with smooth muscle differentiation and a protracted clinical course. Nature Clinical Practice Oncology, 2005, 2:588-593.

35. Patton KT, Cheng L, Papavero V, Blum MG, Yeldandi AV, Adely BP, Luan C, Diaz LK, Hui P, Yang XJ. Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Modern Pathology 2006, 19:130-140.

36. Fadare O, Parkash V, Carcangiu ML, Hui P. Epithelioid Trophoblastic Tumor: Clinicopathological Features with an Emphasis on Uterine Cervical Involvement. Modern Pathology 2006, 19:75-82.

37. Hui P, Wang HL, Chu PG, Yang B, Huang J, Baergen RN, Sklar J, Yang XY, Soslow RA.  Absence of Y Chromosome in Human Placental Site Trophoblastic Tumor.  Modern Pathology 2007, 20:1055-1060.

38. Zhang MQ, Lin F, Hui P, Chen ZM, Ritter JH, and. Wang HL. Expression of Mucins, SIMA, Villin and CDX2 in Small Intestinal Adenocarcinoma. American Journal of Clinical Pathology 2007, 128:808-816.

39. Baehring JM, Landry ML, Cooper D, Hui P, Bannykh S. CSF IgH gene rearrangement analysis in isolated post-transplant lymphoproliferative disorder of the central nervous system. Journal of Neurooncology 2008, 86:57-60.

40. Dotto J, Mezzetti T, Hui P.  Primary or Secondary? Genotyping Confirmation of Ovarian Primary Carcinoid Tumor. International  Journal of  Gynecological Pathology 2008, 27:33-36.

41. De Stefano D, Li P, Xiang B, Hui P, Zambrano E. Pulmonary atresia with intact ventricular septum (PA-IVS) in monozygotic twins. American Journal of Medical Genetics 2008, 146: 525-528.

42. Hala R. Makhlouf HR, Ahrens W, Agarwal B, Dow N, Marshalleck JM, Lee EL, Dotto JE, Hui P, Sobin L, Oliveira A, and Miettinen M.  Synovial sarcoma of the stomach- a clinicopathological, immunohistochemical and molecular genetic study of 10 cases.  American Journal of Surgical Pathology 2008, 32:275-281.

43. Bifulco C, Jonhson C, Hao LM, Kermalli H, Bell S, Hui P. Genotypic Analysis of Hydatidiform Mole: An Accurate and Practical Method of Diagnosis. American Journal of Surgical Pathology 2008, 32:445-451.

44. He HY, Lau J, Hui P, Weiss LM, Chu PG. Expression of CD56 and WT1 in Ovarian Stroma and Ovarian Stromal Tumors. American Journal of Surgical Pathology 2008, 32: 884-890.

45. Xu YC, Dotto J, Hui Y, Lawton K, Schofield K, Hui P. Squamous Dysplasia of Uterine Cervix: Age Correlation with Viral Load of High-Risk Human Papillomavirus Infection. International Journal of Clinical and Experimental Pathology 2008, 2:169-175.

46. Dotto, J, Hui P. Lack of Genetic Association between Exaggerated Placental Site Reaction and Placental Site Trophoblastic Tumor. International Journal of Gynecological Pathology 2008, 27: 562-567.

47. Xu M, Yang Bin, Maria-Luisa Carcangiu, Hui P. Epithelioid Trophoblastic Tumor: Comparative Genomic Hybridization and Diagnostic DNA Genotyping. Modern Pathology 2009, 22:232-238.

48. Galan A, Hui P, McNiff J. Absence of human herpesvirus 8 in pemphigus and bullous pemphigoid. International Journal of Clinical and Experimental Pathology 2009, 2:456-462.

49. Baehring J, Hui P, Piepmeier J, Bannykh SI. Anaplastic oligoastrocytoma in Turcot syndrome. Journal of Neurooncology 2009, 95:293-298.

50. Mac MT. Chung E, Lin F, Hui P, Blazer BL, Wang HL. Expression of hepatocyte antigen in small intestinal epithelium and  adenocarcinoma. American Journal of Clinical Pathology 2009, 132:80-85.

51. Xu M, Schwartz PE, Rutherford TJ, Azodi M, Santin A, Silasi D, Martel M, Hui P. HER-2/neu Receptor Gene Status in Endometrial Carcinomas: A Tissue Microarray Study. Histopathology 2010,56:263-273.

52. Buza N, Finkelstein A, Hui P, Cohen P, Parkash V. P16 expression in small cell carcinoma of the urinary bladder, International Journal of Surgical Pathology 2010, 18:94-102.

53. Elsahwi K, Bellone S, Cocco E, Casagrande F, Bellone M, Abu-Khalaf, M, Buza N, Tavassoli F, Hui P, Silasi D, Azodi M, Schwartz P, Rutherford T, Santin, A.  In vitro Activity of Pertuzumab in Combination with Trastuzumab in Uterine Serous Papillary Adenocarcinoma. British Journal of Cancer 2010, 102:134-143.

54. Elsahwi K, Bellone S, Cocco E, Casagrande F, Bellone M, Abu-Khalaf, M, Buza N, Fattaneh T, Hui P, Silasi D, Azodi M, Schwartz P, Rutherford T, Pecorelli S, Santin A. Overexpression of EpCAM in Uterine Serous Papillary Carcinoma: Implications for EpCAM-specific Immunotherapy with Human Monoclonal Antibody Adecatumumab (MT201). Molecular Cancer Therapeutics 2010, 9:57-66.

55. Ratner ES, Tuck D, Richter C, Nallur S, Patel RM, Schultz V, Hui P, Schwartz PE, Rutherford TJ, Weidhaas JB. MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecologic Oncology 2010, 118:251-257.

56. Richter CE, Hui P, Buza N, Silasi D, Azodi M, Santin AD, Schwartz PE, Rutherford TJ. Her-2/neu overexpression in vulvar Paget's disease - The Yale experience. Journal of Clinical Pathology 2010, 63:544-547.

57. Ratner E, Lu, Boeke, Barnett, Chin, Pelletier, Blitzblau, Tassi, Hui P, Yu, Santin, Matloff, Zelterman, Slack and Weidhaas. A KRAS-variant in ovarian cancer acts as genetic marker of risk. Cancer Research 2010, 70: 6509-6515.

58. Yan Z, Hui P. Minimal uterine serous carcinoma with extrauterine tumor of identical morphology: an immunohistochemical study of 13 cases. Applied Immunohistochemistry and Molecular Morphology 2010, 18:75-79.

59. Ou-Yang, RJ, Hui P, Yang XJ, Zynger DL. Expression of glypican 3 in placental site trophoblastic tumor. Diagnostic Pathology 2010, 5:64.

60. Cocco E, Bellone S, Varughese J, Carrare L, Guzzo F, Buza  N, Hui P, Silasi D, Ratner E, Azodi M, Schwarz P, Rutherford T, Sergio P, Santin A. Her2/neu extracellular domain shedding in uterine serous carcinoma; implications for immunotherapy with trastuzumab. British Journal of Cancer, 2010 103(6):812-9

61. Siddon A, Hui P.  Glial heterotopia of the uterine cervix: DNA genotyping confirmation of its fetal origin. International Journal of Gynecological Pathology 2010, 29:394-397.

62. Lippata F, Parkash V, Talmor M, Bell S, Chen SP, Maric V, Hui P. Precise DNA Genotyping Diagnosis of hydatidiform moles. Journal of Gynecology and Obstetrics 2010, 115:784-794.

63. Levi AW, Harigopa M, Hui P, Schofield K, Chhieng DC. Comparison of Affirm VPIII and Pap Test in the detection of infectious vaginitis. American Journal of Clinical Pathology 2011, 135: 442-2447.

64. Adenira A, Theoharis C, Hui P, Prasad M, Chhieng D. Reflex BRAF Testing in Thyroid Fine Needle Aspiration Biopsy with Equivocal and Positive Interpretation - A Prospective Study. Thyroid 2011, 21:717-723.

65. Levi, AW, Harigopal M, Hui P, Schofield K, Chhieng D. Use of High Risk Human Papillomavirus Testing in Low Grade Squamous Intraepithelial Lesions. Cancer Cytopathology 2011, 119:228-234.

66. Richter CE, Buza N, Hui P, Silasi D, Azodi M, SantinA, Rutherford T, Schwartz P. Urinary hCG screening in the gynecologic oncology population. Journal of Gynecologic Surgery 2011, 27: 143-146.

67. Steffensen K, Alvero AB, Waldstrom M, Hui P, Holmberg J, Silasi D, Jakobsen A, Rutherford TJ, Mor G, Yang Y. Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early stage ovarian cancer. Journal of Oncology 2011:620523 [Epub].

68. Todeschini P, Cocco E, Bellone S, Varughese J, Carrare L, Guzzo F, Buza, N, Hui P, Dan-Arin S, Rathner E, Azodi M, Schwarz P, Rutherford T, Sergio P, Santin A. Her2/neu extracellular domain shedding in uterine serous carcinoma; implications for immunotherapy with trastuzumab. British Journal of Cancer 2011, 105:1176-1182.

69. Adeniran AJ, Hui P, Chhieng D, Prasad ML, Schofield K, Theoharis C. BRAF Mutation Testing of Thyroid FNA Specimens Enhances Predictability of Malignancy in Thyroid Follicular Lesions of Undetermined Significance. Acta Cytologica 2011, 55:570-575.

70. ElSahwi KS, Barber E, Illuzzi J, Buza N, Ratner E, Silasi D, Santin A, Azodi M, Schwartz, Hui P, Rutherford RJ (Corrigendum).  The significance of perineural invasion in early-stage cervical cancer. Gynecologic Oncology 2011, 123:561-564.

71. Varughese J, Hui P, Lu L, Yu H, Schwartz PE. Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression.  Journal of Oncology 2011:628084 [Epub ].

72. Guzzo F, Bellone S, Buza N, Hui P, Carrara L, Varughese J, Cocco E, Betti M, Todeschini P, Gasparrini S, Schwartz PE, Rutherford TJ, Angioli R, Pecorelli S, Santin AD. HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas. International Journal of Gynecological Pathology 2012, 31:211-221.

73. Finkelstein A, Levy GH, Hui P, Prasad A, Theoharis CG, Kowalski D, Chhieng D, Carling T, Roman S, Sosa JA, Udelsman R, Prasad M.  Papillary Thyroid Carcinomas with and without BRAFV600E Mutations are Morphologically Distinct. Histopathology 2012, 60:1052-1059.

74. Levi AW, Beckman D, Hui P, Schofield K, Harigopal M, Chhieng D. Comparing two methods of detection for Chlamydia trachomatis in liquid-based Papanicolaou test. American Journal of Clinical Pathology 2012, 128:236-240.

75. Cai GP, Mahooti S, Lipata FM, Chhieng D, Hui P.  Diagnostic Value of K-ras Mutation Analysis for Pancreaticobiliary Cytology Specimens with Indeterminate Diagnosis. Cancer Cytopathology 2012;120(5):313-8

76. Virk R, Van Kyke Al, Finkelstein A, Gibson J, Prasad A, Hui P, Theoharis C, Carling T, Sanziana A, Roman S, Julie A Sosa J, Udelsman R,  Prasad M. BRAF V600E Mutation in Papillary Thyroid Microcarcinoma: A Genotype Phenotype Correlation. Modern Pathology, 2013, 26(1):62-70.

77. Zhao S, Choi M, Overton JD, Bellone  S, Roque  DM, Cocco  E, Guzzo  F, English DP, Varughese  J, Gasparrini S, Bortolomai  I, Buza N, Hui P, Abu-Khalaf M , Ravaggi A, Bignotti  E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S,  Silasi D, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD. Landscape of Somatic Single Nucleotide and Copy Number Mutations in Uterine Serous Carcinoma. PNAS, 2013, 110(8): 2916-2921.

78. Zhong HH, Liu Y, Talmor M, Wu BQ, Hui P. Deparaffinization and Lysis by Hydrothermal Pressure (Pressure Cooking) Coupled with Chaotropic Salt Column Purification: a Rapid and Efficient Method of DNA Extraction from Formalin-Fixed Paraffin Embedded Tissue. Diagnostic Molecular Pathology 2013, 22(1):52-8.

79. Buza N, Hui P. Partial Hydatidiform Mole: Histological Parameters in Correlation with DNA Genotyping. International Journal of Gynecological Pathology 2013, 32(3): 307-15.

80. Gunal A, Hui P, Kilic S, Xu, R, Jain D, Mitchell K, Robert M, Kenney, B. KRAS Mutations are Associated With Specific Morphologic Features in Colon Cance. Journal of Clinical Gastroenterology. 2013; 47(6):509-14.

81. Alomari A, Hui P, Xu M. Composite Peripheral T-cell Lymphoma, Not Otherwise Specified and B-cell Small Lymphocytic Lymphoma Presenting With Hemophagocytic Lymphohistiocytosis. International Journal of Surgical Pathology. 2013;21(3):303-308.

82. Liu M, Mor G, Cheng H, Xue Xiang X, Hui P, Rutherford T, Ying G, Rimm D, Holmberg J, Alvero A, Silasi D. High frequency of putative ovarian cancer stem cells with CD44 and CK19 co-expression is associated with chemoresistance and decreased progression-free intervals in patients with recurrent epithelial ovarian cancer. Reprod Sci. 2013, 20(5):605-615.

83. Alomari A, Abi-Raad R, Buza, Hui P. Frequent KRAS Mutation in Complex Mucinous Epithelial Lesions of the Endometrium. Modern Pathology, 2013;27(5):675-680.

84. Liu Y, Wu BQ, Zhong HH, Hui P, Fang WG. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing. Int J Clin Exp Pathol. 2013, 6(9):1880-9.

85. Orsaria M, Khelifa  S, Buza N, Kamath A, Hui P. Chromosome 17 polysomy: Correlation with Histological Parameters and HER2NEU Gene Amplification. Journal of Clinical Pathology, 2013, 66(12): 1070-1075.

86. Buza N, English DP, Santin AD, Hui P. Toward Standard HER2 Testing of Endometrial Serous Carcinoma: Four-Year Experience At A Large Academic Center and Recommendations for Clinical Practice. Mod Pathol, 2013, 26(12): 1605-1612.

87.   Bernstein J, Virk T, Hui P, Prasad A, Westra W, Tallini G, Adebowale J. Adeniran A,  Udelsman R, Sasaki C, Roman S, Sosa J, Prasad M. Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathological Features with BRAFV600E Mutational Analysis. Thyoid, 2013, 23(12):1525-1531.

88.  Buza N, Hui P. Marked Heterogeneity of HER2/NEU Gene Amplification in Endometrial Serous Carcinoma. Genes, Chromosomes and Cancer, 2013, 52(12):1178-1186.

89.  Cai G, Wong R, Chhieng D, Levy G, Gettinger S, Roy H, Puchalski J, Homer R. Hui P.  Identification of Epidermal Growth Factor Receptor (EGFR) Mutation, KRAS Mutation, and ALK Gene Rearrangement in the Cytological Specimens of Primary and Metastatic Lung Adenocarcinomas. Cancer Cytopathology, 2013, 121(9): 500-507.

90. Schalper KA, Kumar S, Tavassoli F, Hui P, Rimm D, Gershkovich D: A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in-situ hybridization in breast carcinomas: impact of 2007 American Society of Clinical Oncology/College of American Pathologist criteria. Archives of Pathology and Lab medicine. Arch Pathol Lab Med. 2014, 138(2): 213-219.

91. Much M, Buza N, Hui P. Tissue Identity Testing of Cancer by Short Tandem Repeat Polymorphism: Pitfalls of Interpretation in the Presence of Microsatellite Instability. Human Pathology, 2013,45(3): 549-555.

92. Zheng XZ, Hui P, Chang B, Gao ZB, Li Y, Wu BQ, Zhang B. STR DNA genotyping of hydatidiform moles in South China. Int J Clin Exp Pathol. 2014, 15;7(8):4704-4719.

93. English DP, Bellone S, Schwab CL, Bortolomai I, Bonazzoli E, Cocco E, Buza N, Hui P, Lopez S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Santin AD. T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous carcinoma in vitro and in vivo. Cancer Med. 2014, 3(5):1256-1265.

94. Ahmad AK, Hui P, Litkouhi B, Azodi M, Rutherford T, McCarthy S, Xu ML, Schwartz PE, Ratner E. Institutional Review of Primary Non-Hodgkin Lymphoma of the Female Genital Tract: A 33-Year Experience. Int J Gynecol Cancer. 2014, 24(7):1250-1255.

95. Buza N, Xu F, Wu W, Carr RJ, Li P, Hui P. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study. Hum Pathol.  2014, 45(9):1885-92

96. Abi-Raad R, Al-Omari A, Hui P, Buza N. Mitotically Active Microglandular Hyperplasia Of The Cervix: A Case Series With Implications For The Differential Diagnosis. International Journal of Gynecological Pathology, 2014, 33(5):524-30.

97. Nicoletti R, Lopez S, Bellone S, Cocco E, Schwab CL, Black JD, Centritto F, Zhu L, Bonazzoli E, Buza N, Hui P, Mezzanzanica D, Canevari S, Schwartz PE, Rutherford TJ, Santin AD. T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2. Clin Exp Metastasis. 2015, 32(1): 29-28.

98. Carr R, Hui P, Buza N. Intravenous Leiomyomatosis Revisited: An Experience of 14 Cases at a Single Medical Center. International Journal of Gynecological Pathology, 2015, 34(2):169-176.

99. Alomari A, Glusac EJ, Choi J, Hui P, Seeley EH, Caprioli RM, Watsky KL, Urban J, Lazova R. Congenital melanocytic nevi versus metastatic melanoma in a newborn to a mother with melanoma – diagnosis supported by sex chromosome analysis and imaging mass spectrometry. Journal of Cutaneous Pathology, 2015, 42(10):757-764.

100. Hong W, Abi-Raad A, Alomari AK, Hui P, Buza N. Diagnostic Application of KRAS Mutation Testing in Uterine Microglandular Proliferation. Human Pathology, 2015, 46(7):1000-1005.

101. Levi AW, Bernstein JI, Hui P, Duch K, Schofield K, Chhieng DC. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes. Arch Pathol Lab Med. 2016 Feb;140(2):153-7.

102. Wilson P, Buza N, Hui P.  Progression of endometrial hyperplasia: a revisit under the 2014 WHO classifications. Int J Clin Exp Patholo. 2016;9(2): 1617-1625.

Text Books

103. Cytology and Surgical Pathology of Gynecologic Neoplasms, First Edition, ed. Chhieng D and Hui P. Springer Publishing, 2011, ISBN 978-1-60761-163-9.

104. Gestational Trophoblastic Disease: Diagnostic and Molecular Genetic Pathology. First Edition, ed. Hui P. Springer Publishing, 2012, ISBN: 978-1-61779-393-6.

105. Atlas of Intraoperative Consultation of Gynecologic Pathology, First Edition, ed. Hui P, Buza N, Springer Publishing, 2015, ISBN: 978-3-319-21806-9

Book Chapters and Reviews

106. Hui P, Wu BQ, Zheng J: Carcinoma induction on xenotransplants of human fetal tracheobronchi; in Wu BQ, Zheng J (ed): Immune-deficient animals in experimental medicine (Proceedings of the 6th Int. Workshop on Immune-Deficient Animals), Basel, Karger, 1989, pp 107-111.

107. Tallini G, Hui P. Molecular Diagnosis of Sarcomas, in Molecular Pathology in Clinical Practice, Chapter 28, edited by Leonard, Bagg, Caliendo, Kaul, Snow-Bailey and Van Deerlin, Springer, 2007, Page 287-297.

108. Hui P. Genomic Imprinting, X Chromosome Inactivation and Gestational Trophoblastic Diseases. Edited Review, in "Sex Chromosome: Genetics, Abnormalities, and Disorders", Chapter 3, edited by Weingarten and Jefferson (Nova Science), 2009, Page 43-62.

109. Schwartz PE, Santin AD, Hui P. Uterine serous carcinoma. In ESGO Handbook, 2012.

110. Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects (invited review). Advances in Anatomic Pathology 2005, 12:116-125.

111. Hui P. Pathogenesis of endometrial cancer: clinicopathologic implications (invited review). Chinese Journal of Pathology 2006, 35:705-707.

112. Hui P. Epigenetics of gestational trophoblastic disease: genomic imprinting and X chromosome inactivation. International Journal of Medical and Biological Frontiers 2010,16:915-934.

113. Hui P. Molecular Diagnosis of Gestational Trophoblastic Disease (Invited review). Expert Review of Molecular Diagnostics 2010, 10:1023-1034.

114. Buza N, Hui P. Gestational Trophoblastic Diseases: Histological Diagnosis in the Molecular Era (invited review). Diagnostic Histopathology 2010, 16:526-537.

115. Flynn C. Hui P. Minimal Uterine Serous Carcinoma (MUSC) with Extrauterine Spread: An Easily Overlooked Endometrial Malignancy (invited review). Pathology Case Reviews 2011, 16:104-107.

116. Ziai J, Hui P. BRAF mutation testing in clinical practice (invited review). Expert Review of Molecular Diagnostics 2012, 12:127-138.

117. Buza N, Hui P. New Diagnostic Modalities for Molar Gestations (invited review). Diagnostic Histopathology 2012, 18:201-209.

118. Hui P. Molecular Diagnosis of Hydatidiform Moles is Ready for Primetime (Editorial). Journal of Clinical and Experimental Pathology 2012, 2:1.

119. Hui P, Liu Y. Molecular Pathogenesis of Hydatidiform Mole (Expert Commentary), Chinese Journal of Pathology 2012, 41(11):721-724.

120. Theoharis C and Hui P. Molecular Diagnosis of Thyroid Samples, In "Surgery of the Thyroid and Parathyroid Glands", second edition, edited by Oertili and Udelsman (Springer), 2012, ISBN 978-3-642-23459-0

121. Hui P. Next Generation Sequencing: Chemistry, Technology and Applications. Topics in Current Chemistry  2014;336:1-18.

122. Hui P. Next generation of sequencing for clinical practice. ed. Tang,  "Chemical Diagnostics", Springer, 2013, September, ISBN 978-3-642-39941-1.

123. Buza N, Hui P. Ancillary techniques to refine diagnosis of GTD (invited review). Current Obstetrics and Gynecology Reports, 3:65-75, 2014.

124. Bao F, Chen GR, Hui P, Cai GP. Diagnosis, Grading and Prognostic Molecular Marks of Pancreatic neuroendocrine neoplasm (in Chinese). The Chinese Journal of Pathology, 42:426-432, 2013.

125. Hui P (Responsible author), Baergen R, Cheung ANY, Fukunaga M, Gersell D, Lage JM, Ronnett BM, Sebire NJ, Wells M. Gestational trophoblastic neoplasms, Chapter 6 – Gestational trophoblastic disease, WHO Classification of Tumours of Female Reproductive Organs, 4th Edition. Edited by Kurman R, Young R, Herrington S, Carcangiu M. International Agency for Research on Cancer (IARC) of World Health Organization (WHO), 2014.

126. Buza N, Hui P. Immunohistochemistry and other ancillary techniques in the diagnosis of gestational trophoblastic diseases. Seminars in Diagnostic Pathology, 2014, 31(3):223-32.

127. Adeniran AJ, Hui P. Best Practice of BRAF V600E Mutation Testing for the Diagnosis and Management of Thyroid Cancers. Expert Review of Endocrinology & Metabolism. 2014, 9:571-577.

128. Zheng X, Wu B, Buza N, Hui P. Ancillary techniques in refining the diagnosis of hydatidiform mole. Chinese Journal of Pathology 2015, 44(1):15-20.

129. Perincheri S, Hui P. KRAS mutation testing in clinical practice. Expert Review of Molecular Diagnostics (invited review). 2015, 1593): 375-384.

130. Arleo EL, Schwartz PE, Hui P, McCarthy S: Review of leiomyoma. American J Roentgenology 2015, 205 (4), 912-921.

131. Buza N, Hui P. Gestational trophoblastic disease: Precancerous and putative precancerous lesions. In: Precancerous Lesions of the Gynecologic Tract: Diagnostic and Molecular Genetic Pathology; Springer, 2016, Ed.: Fadare O. Page 85-102.

132. Buza N, Ziai J, Hui P. Mismatch Repair Deficiency Testing in Clinical Practice. Expert Rev Mol Diagn. 2016 Feb 19. [Epub ahead of print]

133. Tallini G, De Biase G. Hui P.  Sarcomas and Related Msenchymal Tumors, in  “Molecular Pathology in Clinical Practice”, Second Edition, edited by Leonard, et al (Springer), 2016. ISBN 978-3-319-19673-2. Page 487-504.

Invited Editorials and Commentaries

134. Hui P: Recent advances in cervical and endometrial carcinoma and application of new techniques (Editorial).  Chinese Journal of Pathology 2002, 31:389-390.

135. Liu CR, Hui P. Molecular Diagnosis of Hydatidiform Mole (Expert Commentary). Chinese Journal of Pathology 2011, 40:6-10.

136. Hui P. Molecular Diagnosis of Hydatidiform Moles is Ready for Primetime (Editorial). Journal of Clinical and Experimental Pathology 2012, 2:1.

137. Oktay M, Hui P. Molecular Pathology as the Driving Force for Personalized Oncology. Expert Review of Molecular Diagnostics. 2012, 12:811-813.

Case Reports, Technical Notes, Letters

138. Hui P, Mu Y: Computer Diagnosis of Congenital Malformations - (Edition 3.10), First Edition, Publication of Scientific Development Center, Peking University/Beijing Medical University, 1988.

139. Hui P, Mu Y: Computer Diagnosis of Congenital Malformations - (Edition 3.20), Second Edition, Publication of Scientific Development Center, Peking University/Beijing Medical University, 1990.

140. Ernst LM, Hui P, Parkash V: Intraplacental smooth muscle tumor: a case report. International Journal of Gynecological Pathology 2001, 20:284-288.

141. Hui P. New Insights in the War against Cancer (invited correspondence). World Journal Monthly (Chinese), New York, January 2001.

142. Tang L, Hui P, Garcia-Tsao G, Salem R, Jain D:  Multiple angiomyolipoma of the liver: a case report. Modern Pathology 2002, 15:167-171.

143. Ma L, Kowalski D, Javed K, Hui P. Atypical Angiomyolipoma of Kidney in Patient with Tuberous Sclerosis: a Case Report with p53 Gene Mutation Analysis. Archive Pathology and Laboratory Medicine 2005, 129:676-679.

144. Wang YN, Kelifa S, Hui P. Müllerian Endometrioid Adenocarcinoma Arising from Colonic Endometriosis / Endosalpingiosis: Report of a case that presented with bowel obstruction. Internet Pathology Journal 2009, 8:1.

145. Finkelstein A, Levy, GH, Hui P. Clear cell adenocarcinoma of the colon arising in the background of endometriosis: a case report and classification approach. Laboratory Medicine 2010, 41: 111-114.

146. Hui P. Yale Doctors Without Border, Newsletter (Spring 2011), Yale School of Medicine, Department of Pathology. http://www.yalepath.org/news/pathnews.htm

147. Bossuyt V, Buza N, Ngo N, Much M, Asis M, Schwartz P, Hui P. Cancerous “Floater” – A Lesson Learnt about Tissue Identity Testing, Endometrial Cancer and Microsatellite Instability. Modern Pathology, 2013; 26(9): 1264-1269.

148. Buza N, Rutherford T, Hui P. Genotyping Diagnosis of Non-gestational Choriocarcinoma involving fallopian tube and broad ligament: a Case Study. International Journal of Gynecological Pathology, 2014, 33(1):58-63.

149. Schwartz PE, Hui P, McCarthy S.  Hormonal Therapy for Aggressive Angiomyxoma: A Case Report and Proposed Management Algorithm. J Low Genit Tract Dis. 2014, 18:E55-61.

150. Buza N., Hui P. Egg donor pregnancy: A potential pitfall in DNA genotyping diagnosis of hydatidiform moles. International Journal of Gynecological Pathology, 2014 33(5): 507-10.

151. Alomari AK, Kelley BJ, Damisah E, Marks A, Hui P, DiLuna M, Vortmeyer A: Craniopharyngioma Arising In a Rathke's Cleft Cyst. Journal of Neurosurgery, 2015, 15(3):250-254.

152. Munday W, Hui, P. Heterozygous bone marrow in a homozygous mature ovarian teratoma: a challenge to the germ cell theory or incidental somatic heterotopia? Journal of Clinical Pathology, 2015, 68(8):666-669

Scholarship In Press (Original research, book chapters, reviews, case reports, others)

153. Cai GP, Bernstein J, Aslanian HR, Hui P, Chhieng D: Endoscopic ultrasound-guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic clues and pitfalls. Journal of the American Society of Cytopathology, in press.